TR200003299T2 - Oxyiminoalkanoic acid derivatives. - Google Patents

Oxyiminoalkanoic acid derivatives.

Info

Publication number
TR200003299T2
TR200003299T2 TR2000/03299T TR200003299T TR200003299T2 TR 200003299 T2 TR200003299 T2 TR 200003299T2 TR 2000/03299 T TR2000/03299 T TR 2000/03299T TR 200003299 T TR200003299 T TR 200003299T TR 200003299 T2 TR200003299 T2 TR 200003299T2
Authority
TR
Turkey
Prior art keywords
acid derivatives
oxyiminoalkanoic acid
oxyiminoalkanoic
retinoid
receptor function
Prior art date
Application number
TR2000/03299T
Other languages
Turkish (tr)
Inventor
Momose Yu
Odaka Hiroyuki
Imoto Hiroshi
Kimura Hiroyuki
Sakamoto Junichi
Original Assignee
Takeda Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd. filed Critical Takeda Chemical Industries, Ltd.
Publication of TR200003299T2 publication Critical patent/TR200003299T2/en

Links

Abstract

Mevcut bulus hipoglisemik etkiye ve hipolipidemik etkiye sahip yeni oksiiminoalkanoik asit türevlerine, bir oksiiminoalkanoik asit ihtiva eden yeni bir farmasötik bilesime ve retinoit baglantili reseptör fonksiyonu düzenleyicisine iliskindir. Bu tür yeni oksiiminoalkanoik asit türevleri, farmasötik bilesimler ve retinoit baglantili reseptör fonksiyonu düzenleyiciler seker hastaligi, hiperlipidemi, azalan glükoz toleransi, enflamatuvar hastalik, arterioskleroz ve benzerinin önlenmesine ve/veya tedavisine mahsus bir ajan olarak faydalidirlar.The present invention relates to new oxyiminoalkanoic acid derivatives with hypoglycemic effect and hypolipidemic effect, a new pharmaceutical composition containing an oxyiminoalkanoic acid, and a retinoid-linked receptor function regulator. Such novel oxyiminoalkanoic acid derivatives, pharmaceutical compositions, and retinoid-linked receptor function regulators are useful as agents for the prevention and / or treatment of diabetes, hyperlipidemia, decreased glucose tolerance, inflammatory disease, arteriosclerosis, and the like.

TR2000/03299T 1998-05-11 1999-05-10 Oxyiminoalkanoic acid derivatives. TR200003299T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP79211998 1998-05-11
JP12792298 1998-05-11

Publications (1)

Publication Number Publication Date
TR200003299T2 true TR200003299T2 (en) 2001-05-21

Family

ID=26463749

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03299T TR200003299T2 (en) 1998-05-11 1999-05-10 Oxyiminoalkanoic acid derivatives.

Country Status (1)

Country Link
TR (1) TR200003299T2 (en)

Similar Documents

Publication Publication Date Title
TR200003244T2 (en) New use
TR199800585T2 (en) (Methylsulfonyl)Phenyl-2-(5H)-Furanons as COX-2 Inhibitors.
TR199901578T2 (en) Clarithromycin form 0 crystals
EA200200921A1 (en) Malonic Acid Polyamides and Their Derivatives as Ligands of Thyroid Receptors
BR9707064A (en) New 19-nor-pregnene derivatives
BR9909358A (en) Compound, pharmaceutical composition, and, process to prevent or alleviate chronic complications resulting from diabetes mellitus
TR200100238T2 (en) Newly substituted pyrazole derivatives
TR200101412T2 (en) New compounds.
BG103264A (en) Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
PT1075259E (en) NEW FATAL ANALOGS FOR THE TREATMENT OF DIABETES
ATE212343T1 (en) 3,4-DIARYL-2-HYDROXY-2,5-DIHYDROFURANES AS PRECURSORS OF COX-2 INHIBITORS
AU1973997A (en) Pentafluorobenzenesulfonamides and analogs
ATE308327T1 (en) USE OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES AS ACTIVE INGREDIENTS FOR CHEMOPREVENTION AND CHEMOTHERAPY OF COLON CANCER
BR0101527A (en) Thyroid receptor ligands
ES2193241T3 (en) NEW N-2-OXO2.3.4.5-TETRAJODRP-1H-1,5-BENZODIAZEPIN-3-IL) -3-AMIDAS.
TR199800521T1 (en) Seimli beta3 adrenerjik agonistler.
TR200200125T2 (en) New aminothiazole derivatives, their preparation and pharmaceutical compositions containing them.
NO981393L (en) Guanidinoproteasehemmere
DE59610175D1 (en) HYDANTO DERIVATIVES AS INTERMEDIATE PRODUCTS FOR PHARMACEUTICAL ACTIVE SUBSTANCES
RU94038042A (en) Derivatives of hexahydroazepine, pharmaceutical composition based on thereof and antipsychotropic agent
TR200003299T2 (en) Oxyiminoalkanoic acid derivatives.
BR0013313A (en) Substituted pyrrolidine-2,3,4-trione-3-oxin derivatives effective as nmda receptor antagonists
TR200504091T2 (en) (7alpha, 17alpha) -17-hydroxy-7-methyl-19-nor-17-pregn-5 (10) -en 20-yn-3-one.
DE60227421D1 (en) RMAZEUTICAL COMPOSITION AND USE THEREOF
DE69508605D1 (en) PROINSULIN PEPTIDE COMPOUNDS FOR DETECTING AND TREATING TYPE I DIABETES